Bloomberg -- Merck & Co.’s vaccine for warding off a virus that causes cervical cancer in women also reduces infection rates and genital warts in young men, according to a study in the New England Journal of Medicine.
Bloomberg -- Merck & Co.’s vaccine for warding off a virus that causes cervical cancer in women also reduces infection rates and genital warts in young men, according to a study in the New England Journal of Medicine.
